[go: up one dir, main page]

EP4518851A4 - Compositions et méthodes de traitement de l'épilepsie - Google Patents

Compositions et méthodes de traitement de l'épilepsie

Info

Publication number
EP4518851A4
EP4518851A4 EP24719451.7A EP24719451A EP4518851A4 EP 4518851 A4 EP4518851 A4 EP 4518851A4 EP 24719451 A EP24719451 A EP 24719451A EP 4518851 A4 EP4518851 A4 EP 4518851A4
Authority
EP
European Patent Office
Prior art keywords
epilepsy
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24719451.7A
Other languages
German (de)
English (en)
Other versions
EP4518851A2 (fr
Inventor
John Docherty
Christopher Andrew Bunka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poviva Corp
Original Assignee
Poviva Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US18/225,234 external-priority patent/US11986485B1/en
Priority claimed from US18/225,244 external-priority patent/US12023346B1/en
Priority claimed from US18/225,227 external-priority patent/US11931369B1/en
Application filed by Poviva Corp filed Critical Poviva Corp
Publication of EP4518851A2 publication Critical patent/EP4518851A2/fr
Publication of EP4518851A4 publication Critical patent/EP4518851A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP24719451.7A 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie Pending EP4518851A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18/225,234 US11986485B1 (en) 2023-07-24 2023-07-24 Compositions and methods for treating epilepsy
US18/225,244 US12023346B1 (en) 2023-07-24 2023-07-24 Compositions and methods for treating epilepsy
US18/225,227 US11931369B1 (en) 2023-07-24 2023-07-24 Compositions and methods for treating epilepsy
PCT/US2024/016571 WO2025024008A2 (fr) 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie

Publications (2)

Publication Number Publication Date
EP4518851A2 EP4518851A2 (fr) 2025-03-12
EP4518851A4 true EP4518851A4 (fr) 2025-07-30

Family

ID=91027066

Family Applications (3)

Application Number Title Priority Date Filing Date
EP24719451.7A Pending EP4518851A4 (fr) 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie
EP24719452.5A Pending EP4522133A1 (fr) 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie
EP24719450.9A Pending EP4522159A4 (fr) 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP24719452.5A Pending EP4522133A1 (fr) 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie
EP24719450.9A Pending EP4522159A4 (fr) 2023-07-24 2024-02-20 Compositions et méthodes de traitement de l'épilepsie

Country Status (6)

Country Link
EP (3) EP4518851A4 (fr)
JP (2) JP2025529609A (fr)
AU (3) AU2024202447B2 (fr)
CA (3) CA3236758A1 (fr)
MX (3) MX2024008085A (fr)
WO (3) WO2025024008A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017100062A1 (fr) * 2015-12-09 2017-06-15 Poviva Tea, Llc Procédés pour la formulation de compositions ingérables par voie orale comprenant des agents actifs lipophiles
US20200368179A1 (en) * 2014-06-17 2020-11-26 GW Research Limited Use of cannabinoids in the treatment of epilepsy
WO2020236802A1 (fr) * 2019-05-20 2020-11-26 Poviva Corp. Compositions comprenant des agents biologiquement actifs et des sels biliaires
US11666544B1 (en) * 2022-07-05 2023-06-06 Poviva Corp. Compositions and methods for treating hypertension

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009536165A (ja) * 2006-05-10 2009-10-08 エボニック デグサ ゲーエムベーハー 医薬組成物におけるロール圧縮された熱分解的に製造された二酸化ケイ素の使用
US10350251B2 (en) * 2012-03-28 2019-07-16 Keith Gerald Freeman Medical compositions, methods of making and using those compositions, and kits including those compositions
BR102015024165A2 (pt) * 2015-09-18 2017-03-28 Prati Donaduzzi & Cia Ltda composição farmacêutica oral compreendendo canabinóide, processo para sua preparação e seu uso
US10265362B2 (en) * 2016-04-12 2019-04-23 Scott Schaneville Ingestible films having substances from hemp or cannabis
EP3478270A4 (fr) * 2016-06-02 2019-11-27 Acerus Labs, Inc. Formulations nasales liquides semi-solides et visqueuses nasales liquides de cannabinoïdes
EP3820452A1 (fr) * 2018-07-09 2021-05-19 Volker Berl Formulations stabilisées de compositions cannabinoïdes
US11026896B2 (en) * 2019-06-18 2021-06-08 Dyve Biosciences, Inc. Transdermal penetrant formulations containing cannabidiol
WO2021092428A1 (fr) * 2019-11-08 2021-05-14 Ellevet Sciences Extrait de chanvre et ses méthodes d'utilisation
MX2022013090A (es) * 2020-04-20 2022-11-14 Poviva Corp Composiciones y metodos para el suministro mejorado de agentes antivirales.
US20240050450A1 (en) * 2020-10-16 2024-02-15 Michael Ogburn Inhalable Cannabinoid Formulations
WO2022125882A1 (fr) * 2020-12-11 2022-06-16 Michael Ogburn Formulations de capsules orales de cannabinoïdes
US20220241199A1 (en) * 2021-02-01 2022-08-04 Douglas Gore Cannabinoid emulsion composition and method of manufacture
US11666543B1 (en) * 2022-07-05 2023-06-06 Poviva Corp. Pharmaceutical compositions and methods for treating hypertension
US12023346B1 (en) * 2023-07-24 2024-07-02 Poviva Corp Compositions and methods for treating epilepsy

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200368179A1 (en) * 2014-06-17 2020-11-26 GW Research Limited Use of cannabinoids in the treatment of epilepsy
WO2017100062A1 (fr) * 2015-12-09 2017-06-15 Poviva Tea, Llc Procédés pour la formulation de compositions ingérables par voie orale comprenant des agents actifs lipophiles
WO2020236802A1 (fr) * 2019-05-20 2020-11-26 Poviva Corp. Compositions comprenant des agents biologiquement actifs et des sels biliaires
US11666544B1 (en) * 2022-07-05 2023-06-06 Poviva Corp. Compositions and methods for treating hypertension

Also Published As

Publication number Publication date
WO2025024009A1 (fr) 2025-01-30
AU2024202475B2 (en) 2025-04-10
WO2025024008A2 (fr) 2025-01-30
EP4518851A2 (fr) 2025-03-12
CA3236769A1 (fr) 2025-06-17
MX2024008084A (es) 2025-08-01
WO2025024008A3 (fr) 2025-04-17
CA3236789A1 (fr) 2025-06-17
AU2024202447B2 (en) 2025-02-27
MX2024008085A (es) 2025-03-07
WO2025024007A1 (fr) 2025-01-30
JP2025527042A (ja) 2025-08-18
CA3236758A1 (fr) 2025-06-17
AU2024202475A1 (en) 2025-02-06
EP4522133A4 (fr) 2025-03-19
JP2025529609A (ja) 2025-09-09
AU2024202439B2 (en) 2025-09-11
AU2024202447A1 (en) 2025-02-06
AU2024202439A1 (en) 2025-02-06
MX2024008083A (es) 2025-08-01
EP4522159A1 (fr) 2025-03-19
EP4522133A1 (fr) 2025-03-19
EP4522159A4 (fr) 2025-06-04

Similar Documents

Publication Publication Date Title
EP3924481A4 (fr) Compositions et méthodes de traitement d'hémoglobinopathies
MA52631A (fr) Compositions et méthodes pour le traitement de la maladie de parkinson
MA54792A (fr) Compositions et méthodes pour le traitement de la maladie de parkinson
EP4297871A4 (fr) Procédés et compositions pour le traitement de l'agitation
EP3927428A4 (fr) Méthodes de traitement d'affections respiratoires
EP3920898A4 (fr) Méthodes et compositions pour le traitement de l'apnée du sommeil
EP4326277A4 (fr) Méthodes de traitement de strictions d'sophagiennes
EP4114422A4 (fr) Compositions et méthodes pour le traitement d'infections bactériennes intracellulaires
EP4149547A4 (fr) Compositions et méthodes pour le traitement du cancer
MA55895A (fr) Compositions d'oxymétazoline et procédés de traitement de troubles oculaires
EP4284417A4 (fr) Compositions et méthodes de traitement de l'angi?dème héréditaire
CA3236794A1 (fr) Compositions et methodes pour le traitement de l'epilepsie
EP3920940A4 (fr) Méthodes de prévention et de traitement d'une inflammation et d'une maladie inflammatoire
EP4181877A4 (fr) Méthodes et compositions pour le traitement du syndrome de l'x fragile
MA51787A (fr) Substances et méthodes de traitement d'hémoglobinopathies
EP4384220A4 (fr) Compositions et méthodes de traitement du cancer
EP4188110A4 (fr) Méthodes et compositions pour le traitement d'états métaboliques
EP4284392A4 (fr) Traitement de l'astigmatisme
EP3810647A4 (fr) Méthodes et compositions pour le traitement de l'hémophilie
EP3965799A4 (fr) Compositions et méthodes synergiques de traitement d'infections
EP4100430A4 (fr) Compositions et méthodes de traitement de l'hypertension pulmonaire
EP4146276A4 (fr) Compositions et méthodes de traitement de l'épilepsie
EP4518851A4 (fr) Compositions et méthodes de traitement de l'épilepsie
EP3894564A4 (fr) Méthodes et compositions pour le traitement de l'hyperoxalurie
EP3735129A4 (fr) Compositions et méthodes de traitement de troubles neurologiques et d'autres troubles

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240425

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031352000

Ipc: A61K0031000000

A4 Supplementary search report drawn up and despatched

Effective date: 20250627

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/00 20060101AFI20250623BHEP

Ipc: A61K 31/05 20060101ALI20250623BHEP

Ipc: A61P 25/08 20060101ALI20250623BHEP

Ipc: A61K 9/16 20060101ALI20250623BHEP

Ipc: A61K 9/10 20060101ALI20250623BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20251007